Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
07 2023
Historique:
received: 17 06 2022
accepted: 20 04 2023
pmc-release: 01 05 2024
medline: 16 6 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

Radon is a ubiquitous occupational and environmental lung carcinogen. We aim to quantify the association between radon progeny and lung cancer mortality in the largest and most up-to-date pooled study of uranium miners. The pooled uranium miners analysis combines 7 cohorts of male uranium miners with 7754 lung cancer deaths and 4.3 million person-years of follow-up. Vital status and lung cancer deaths were ascertained between 1946 and 2014. The association between cumulative radon exposure in working level months (WLM) and lung cancer was modelled as the excess relative rate (ERR) per 100 WLM using Poisson regression; variation in the association by temporal and exposure factors was examined. We also examined analyses restricted to miners first hired before 1960 and with <100 WLM cumulative exposure. In a model that allows for variation by attained age, time since exposure and annual exposure rate, the ERR/100 WLM was 4.68 (95% CI 2.88 to 6.96) among miners who were less than 55 years of age and were exposed in the prior 5 to <15 years at annual exposure rates of <0.5 WL. This association decreased with older attained age, longer time since exposure and higher annual exposure rate. In analyses restricted to men first hired before 1960, we observed similar patterns of association but a slightly lower estimate of the ERR/100 WLM. This new large, pooled study confirms and supports a linear exposure-response relationship between cumulative radon exposure and lung cancer mortality which is jointly modified by temporal and exposure factors.

Identifiants

pubmed: 37164624
pii: oemed-2022-108532
doi: 10.1136/oemed-2022-108532
pmc: PMC10369304
mid: NIHMS1915661
doi:

Substances chimiques

Radon Q74S4N8N1G
Uranium 4OC371KSTK
Apoptosis Regulatory Proteins 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-391

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NIOSH CDC HHS
ID : R21 OH011452
Pays : United States
Organisme : NIOSH CDC HHS
ID : R03 OH010946
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Ind Med. 2020 Oct;63(10):859-867
pubmed: 33448434
Radiat Res. 2008 Feb;169(2):125-37
pubmed: 18220460
Health Phys. 2013 Mar;104(3):282-92
pubmed: 23361424
Br J Cancer. 2015 Nov 3;113(9):1367-9
pubmed: 26393888
Int Arch Occup Environ Health. 2015 Aug;88(6):717-30
pubmed: 25410273
Environ Health Perspect. 2022 May;130(5):57010
pubmed: 35604341
Environ Health Perspect. 1995 Mar;103 Suppl 2:49-53
pubmed: 7614947
Occup Environ Med. 2020 Mar;77(3):194-200
pubmed: 32005674
Radiat Prot Dosimetry. 2015 Apr;164(1-2):147-53
pubmed: 25267854
J Radiol Prot. 2012 Sep;32(3):301-14
pubmed: 22809823
Radiat Res. 2011 Sep;176(3):375-87
pubmed: 21714633
Radiat Environ Biophys. 2012 Mar;51(1):15-22
pubmed: 22193911
Int J Environ Res Public Health. 2013 Mar 07;10(3):963-79
pubmed: 23470882
Int Arch Occup Environ Health. 2019 Jul;92(5):747-762
pubmed: 30737558
Radiat Res. 2012 Mar;177(3):288-97
pubmed: 22206233
Ann ICRP. 1993;23(2):1-45
pubmed: 8179237
Health Phys. 1995 Oct;69(4):494-500
pubmed: 7558839
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Am J Epidemiol. 2009 Mar 15;169(6):718-30
pubmed: 19208723
IARC Monogr Eval Carcinog Risks Hum. 1988;43:173-259
pubmed: 3065210
Am J Epidemiol. 2015 May 15;181(10):762-70
pubmed: 25837305
Health Phys. 1991 Dec;61(6):745-52
pubmed: 1659563
Radiat Prot Dosimetry. 2014 Jul;160(1-3):124-7
pubmed: 24751983
Ann ICRP. 2020 Dec;49(1_suppl):57-67
pubmed: 32734762
Occup Environ Med. 2016 Dec;73(12):838-845
pubmed: 27651479
Environ Health Perspect. 2018 May 31;126(5):057009
pubmed: 29856911
Radiat Res. 2010 Dec;174(6):773-85
pubmed: 21128801
Radiat Res. 2010 Jan;173(1):79-90
pubmed: 20041762
J Natl Cancer Inst. 1995 Jun 7;87(11):817-27
pubmed: 7791231
Radiat Res. 2018 Feb;189(2):165-176
pubmed: 29215327

Auteurs

Kaitlin Kelly-Reif (K)

Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA kkelly-reif@cdc.gov.

Stephen J Bertke (SJ)

Division of Field Studies and Engineering, National Institute for Occupational Safety and Health, Cincinnati, Ohio, USA.

Estelle Rage (E)

Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.

Paul A Demers (PA)

Occupational Cancer Research Centre, Ontario Health, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Nora Fenske (N)

Federal Office for Radiation Protection (BfS), Munich (Neuherberg), Germany.

Veronika Deffner (V)

Federal Office for Radiation Protection (BfS), Munich (Neuherberg), Germany.

Michaela Kreuzer (M)

Federal Office for Radiation Protection (BfS), Munich (Neuherberg), Germany.

Jonathan Samet (J)

Colorado School of Public Health, Aurora, Colorado, USA.

Mary K Schubauer-Berigan (MK)

Evidence Synthesis and Classification Branch, International Agency for Research on Cancer, Lyon, France.

Ladislav Tomasek (L)

National Radiation Protection Institute, Prague, Czech Republic.

Lydia B Zablotska (LB)

Epidemiology and Biostatistics, University of California, San Francisco, California, USA.

Charles Wiggins (C)

University of New Mexico, Albuquerque, New Mexico, USA.
New Mexico Tumor Registry, Albuquerque, Mexico, USA.

Dominique Laurier (D)

Institute for Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.

David B Richardson (DB)

Department of Environmental and Occupational Health, University of California, Irvine, Program in Public Health, Irvine, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH